Homocysteine and atherothrombosis
GN Welch, J Loscalzo - New England journal of medicine, 1998 - Mass Medical Soc
In 1969, McCully made the clinical observation linking elevated plasma homocyst (e) ine
concentrations with vascular disease. 1 He reported autopsy evidence of extensive arterial …
concentrations with vascular disease. 1 He reported autopsy evidence of extensive arterial …
Homocysteine metabolism
J Selhub - Annual review of nutrition, 1999 - annualreviews.org
▪ Abstract Homocysteine is a sulfur amino acid whose metabolism stands at the intersection
of two pathways: remethylation to methionine, which requires folate and vitamin B12 (or …
of two pathways: remethylation to methionine, which requires folate and vitamin B12 (or …
5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review
LD Botto, Q Yang - American journal of epidemiology, 2000 - academic.oup.com
Abstract The enzyme 5, 10-methylenetetrahydrofolate reductase (MTHFR) is involved in
folate metabolism. The MTHFR gene is located on chromosome 1 (1p36. 3), and two …
folate metabolism. The MTHFR gene is located on chromosome 1 (1p36. 3), and two …
Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders
MP Mattson, TB Shea - Trends in neurosciences, 2003 - cell.com
Folate is a cofactor in one-carbon metabolism, during which it promotes the remethylation of
homocysteine–a cytotoxic sulfur-containing amino acid that can induce DNA strand …
homocysteine–a cytotoxic sulfur-containing amino acid that can induce DNA strand …
Geographic distribution of the 20210 G to A prothrombin variant
FR Rosendaal, CJM Doggen, A Zivelin… - Thrombosis and …, 1998 - thieme-connect.com
A variant in prothrombin (clotting factor II), a G to A transition at nucleotide position 20210,
has recently been shown to be associated with the prothrombin plasma levels and the risk of …
has recently been shown to be associated with the prothrombin plasma levels and the risk of …
Overview and new insights into the metabolic syndrome: risk factors and emerging variables in the development of type 2 diabetes and cerebrocardiovascular disease
MR Hayden - Medicina, 2023 - mdpi.com
Metabolic syndrome (MetS) is considered a metabolic disorder that has been steadily
increasing globally and seems to parallel the increasing prevalence of obesity. It consists of …
increasing globally and seems to parallel the increasing prevalence of obesity. It consists of …
Homocyst (e) ine and cardiovascular disease: a critical review of the epidemiologic evidence
JW Eikelboom, E Lonn, J Genest Jr… - Annals of internal …, 1999 - acpjournals.org
Purpose: To review epidemiologic studies on the association between homocyst (e) ine
level and risk for cardiovascular disease and the potential benefits of homocysteine …
level and risk for cardiovascular disease and the potential benefits of homocysteine …
Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis
L Brattström, DEL Wilcken, J Öhrvik, L Brudin - Circulation, 1998 - Am Heart Assoc
Background—The results of retrospective and prospective case-control studies have clearly
established that mild elevations of the plasma homocysteine level are associated with …
established that mild elevations of the plasma homocysteine level are associated with …
[HTML][HTML] Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies
M Den Heijer, S Lewington, R Clarke - Journal of Thrombosis and …, 2005 - Elsevier
Context: It has been suggested that elevated total plasma homocysteine levels are
associated with the risk of venous thrombosis. Objective: To assess the relationship of …
associated with the risk of venous thrombosis. Objective: To assess the relationship of …
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase …
B Simone, V De Stefano, E Leoncini, J Zacho… - European journal of …, 2013 - Springer
Genetic and environmental factors interact in determining the risk of venous
thromboembolism (VTE). The risk associated with the polymorphic variants G1691A of factor …
thromboembolism (VTE). The risk associated with the polymorphic variants G1691A of factor …